Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOLIPOP paediatric HIV 4-in-1 formulation study
PACTR201903696308665Phase 2Not yet recruiting
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lopinavir, ritonavir, lamivudine and abacavir in human immunodeficiency virus infection (HIV), sponsored by Drugs for Neglected Diseases initiative. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
lopinavirritonavirlamivudineabacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201903696308665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201903696308665.